La hematología aplicada a la clínica /

Autor Mas y Magro, F.
Vydáno 1941.

Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection

Autor Nazareth, N, Magro, F, Silva, J, Duro, M, Gracio, D, Coelho, R, Appelberg, R, Macedo, G, Sarmento, A
Vydáno 2014

Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease – A systematic review and meta-analysis: PS083

Autor Estevinho, M. M., Afonso, J., Rosa, I., Lago, P., Trindade, E., Correia, L., Dias, C. C., Magro, F.
Vydáno v Porto Biomed J (2017)

The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels

Autor Magro, F., Rocha, C., Vieira, A. I., Sousa, H. T., Rosa, I., Lopes, S., Carvalho, J., Dias, C. C., Afonso, J.
Vydáno v Therap Adv Gastroenterol (2018)

Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce

Autor Magro, F, Rahier, J-F, Abeu, C, MacMahon, E, Hart, A, van der Woude, C J, Gordon, H, Adamina, M, Viget, N, Vavricka, S, Kucharzik, T, Leone, S, Siegmund, B, Danese, S, Peyrin-Biroulet, L
Vydáno v J Crohns Colitis (2020)